A Translational Evaluation of Sur1-Trpm4 Imaging Endophenotypes and Genetics to Direct Precision Medicine for Cerebral Edema After Traumatic Brain Injury
Sur1-Trpm4 成像内表型和遗传学的转化评估指导精准医学治疗脑外伤后脑水肿
基本信息
- 批准号:10401300
- 负责人:
- 金额:$ 57.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-05 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectBrainBrain EdemaBrain InjuriesBrain regionCaringCationsCause of DeathCellsCerebral EdemaCerebral Edema ManagementCerebrumClinicalClinical TrialsClinical Trials DesignCollaborationsComplexContusionsCost of IllnessDataDiffuseDiseaseEdemaEvaluationFoundationsFutureGenerationsGenesGeneticGenetic Predisposition to DiseaseGenetic RiskGenetic VariationGlyburideGoalsGrowthGuidelinesHeterogeneityHumanHypotensionIdeal 1ImageIndividualIndividual DifferencesInjuryInternationalInterventionIntracranial PressureKnock-in MouseKnock-outKnowledgeLinkMagnetic Resonance ImagingMapsMeasurableMeasuresMethodologyMissionModelingMolecularMusNational Institute of Neurological Disorders and StrokeOutcomePathway AnalysisPathway interactionsPatient SelectionPatient riskPatientsPersonsPharmaceutical PreparationsPhasePhenotypePhysiologicalPreventiveProbabilityProcessPrognosisPropertyProteinsProtocols documentationResearchResearch PersonnelResourcesRiskSNP genotypingSingle Nucleotide PolymorphismSodiumTestingTimeTransgenic MiceTransgenic OrganismsTranslatingTraumatic Brain InjuryValidationVariantWaterWorkbasecausal variantcell typeclinical careclinical translationclinically relevantcohortcontrolled cortical impactdesigndisabilityearly phase clinical trialeffective therapyendophenotypefluid percussion injuryhigh riskimprovedimproved outcomein vivo evaluationindividual variationinnovationmolecular imagingmolecular phenotypemolecular targeted therapiesmouse modelnervous system disordernoveloperationpatient stratificationphase II trialpotential biomarkerpre-clinicalprecision medicinepreclinical studypreventprotein expressionradiological imagingreceptorresponserisk stratificationsulfonylurea receptortargeted therapy trialstargeted treatmenttherapeutic targettooltreatment optimizationtreatment responsetrial design
项目摘要
For decades, there has been a critical gap in translating preclinical work on mechanisms of cerebral edema in
traumatic brain injury (TBI) to clinically available targeted therapies that improve outcome. This is important
because cerebral edema management commands substantial clinical and financial resources in severe TBI, yet
it remains a common cause of death and disability. Current treatments are indiscriminate, reactionary and morbid
- none improve outcome. Guideline-based protocols use a templated approach to this immensely complex
process without addressing individual differences in contributory pathways or edema endophenotypes. The long
-term goal is to harness relevant individual data (genetic, molecular, imaging, physiologic) to direct a precision
medicine approach to treat TBI edema and related contusion expansion. This R01 focuses on logical next steps
to address existing knowledge gaps in a unique, key edema pathway involving Sulfonylurea receptor-1 (Sur1)
and its regulated cation channel Trpm4. Promising results from Sur-1 inhibition (Glyburide, GLY) in preclinical
and early clinical brain injury trials have generated exciting momentum in this pathway. The objective of this
translational R01 is to define the impact of Sur1-Trpm4 related genetic and protein variability on different edema
endophenotypes, contusion growth and response to inhibition in preclinical and human TBI. The rationale is that
identifying these individual differences directly informs patient risk-stratification, prognosis, trial design, and
targeted therapy; ultimately improving outcome. The central hypothesis is that Sur1 protein expression and
genetic variability influence the endophenotype, extent, and therapeutic response of TBI edema. Aim 1 defines
correlations between Sur1-Trpm4 expression and MRI edema endophenotypes in three clinically relevant
complementary mouse models. Aim 2 tests effects of Sur1 inhibition (GLY, inducible knockout) in these models
on MRI edema endophenotypes, contusion, and outcome. Aim 3 identifies impact of genetic variation in the Sur1
pathway on TBI edema and contusion growth (on imaging) in a single-center human test-cohort, and a
multicenter validation-cohort. The work is feasible as shown by robust preliminary results and the tools, expertise
and track record of successful collaborations among coinvestigators. This work is innovative in concept and
methodology: it shifts a guideline-based paradigm toward precision medicine, links clinically measurable edema
endophenotypes (MRI) with a molecular pathway and targeted inhibition in different TBI models, and uses a
novel transgenic mouse to generate Sur1-Trpm4 expression maps. This research is significant, with high impact
if successful: linking Sur1-Trpm4 expression and inhibition to MRI endophenotypes (Aims 1-2) directly translate
to identifying appropriate patients for targeted therapy and trials. Distinguishing high vs low risk genetic profiles
(Aim-3) will identify patients in whom Sur1-Trpm4 is a major contributor to TBI edema and contusion growth, and
channel inhibition may be highly beneficial- directing clinical care and trials. Ultimately, such knowledge has the
potential to transform precision-medicine care of this devastating secondary injury and improve TBI outcome.
几十年来,在翻译脑水肿机制的临床前工作方面一直存在一个关键的差距
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruchira Menka Jha其他文献
Ruchira Menka Jha的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruchira Menka Jha', 18)}}的其他基金
A Single Cell and Proteomic Precision Medicine Approach to Glyburide Responsive Contusion Expansion in Severe Traumatic Brain Injury
单细胞和蛋白质组精准医学方法治疗严重创伤性脑损伤中的格列本脲反应性挫伤扩张
- 批准号:
10645458 - 财政年份:2023
- 资助金额:
$ 57.35万 - 项目类别:
A Translational Evaluation of Sur1-Trpm4 Imaging Endophenotypes and Genetics to Direct Precision Medicine for Cerebral Edema After Traumatic Brain Injury
Sur1-Trpm4 成像内表型和遗传学的转化评估指导精准医学治疗脑外伤后脑水肿
- 批准号:
10612416 - 财政年份:2021
- 资助金额:
$ 57.35万 - 项目类别:
A Translational Evaluation of Sur1-Trpm4 Imaging Endophenotypes and Genetics to Direct Precision Medicine for Cerebral Edema After Traumatic Brain Injury
Sur1-Trpm4 成像内表型和遗传学的转化评估指导精准医学治疗脑外伤后脑水肿
- 批准号:
10117587 - 财政年份:2021
- 资助金额:
$ 57.35万 - 项目类别:
Translational assessment of sulfonylurea receptor-1 as a biomarker and therapeutic target for cerebral edema in traumatic brain injury
磺酰脲类受体1作为创伤性脑损伤脑水肿生物标志物和治疗靶点的转化评估
- 批准号:
10396240 - 财政年份:2017
- 资助金额:
$ 57.35万 - 项目类别:
Translational assessment of sulfonylurea receptor-1 as a biomarker and therapeutic target for cerebral edema in traumatic brain injury
磺酰脲类受体1作为创伤性脑损伤脑水肿生物标志物和治疗靶点的转化评估
- 批准号:
10183343 - 财政年份:2017
- 资助金额:
$ 57.35万 - 项目类别:
相似海外基金
Understanding how psychedelic drugs affect brain and behaviour in rodents
了解迷幻药物如何影响啮齿类动物的大脑和行为
- 批准号:
2897454 - 财政年份:2023
- 资助金额:
$ 57.35万 - 项目类别:
Studentship
Does Vision Loss Affect Tauopathy in the Brain
视力丧失是否会影响大脑中的 Tau 蛋白病
- 批准号:
10670631 - 财政年份:2023
- 资助金额:
$ 57.35万 - 项目类别:
Neuroplasticity in songbirds: how changing behaviour and experience affect learning and the brain
鸣禽的神经可塑性:行为和经验的变化如何影响学习和大脑
- 批准号:
RGPIN-2018-04060 - 财政年份:2022
- 资助金额:
$ 57.35万 - 项目类别:
Discovery Grants Program - Individual
Understanding brain maturation: How spontaneous cortical high frequency oscillations develop and affect executive function during childhood
了解大脑成熟:自发皮质高频振荡如何发展并影响儿童时期的执行功能
- 批准号:
RGPIN-2021-02948 - 财政年份:2022
- 资助金额:
$ 57.35万 - 项目类别:
Discovery Grants Program - Individual
Peering into the future of neuroscience: how visual cues are processed in the avian brain to affect locomotion
展望神经科学的未来:鸟类大脑如何处理视觉线索以影响运动
- 批准号:
559062-2021 - 财政年份:2022
- 资助金额:
$ 57.35万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Peering into the future of neuroscience: how visual cues are processed in the avian brain to affect locomotion
展望神经科学的未来:鸟类大脑如何处理视觉线索以影响运动
- 批准号:
559062-2021 - 财政年份:2021
- 资助金额:
$ 57.35万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
How does environmental enrichment affect brain development?
丰富的环境如何影响大脑发育?
- 批准号:
DP210102473 - 财政年份:2021
- 资助金额:
$ 57.35万 - 项目类别:
Discovery Projects
Neuroplasticity in songbirds: how changing behaviour and experience affect learning and the brain
鸣禽的神经可塑性:行为和经验的变化如何影响学习和大脑
- 批准号:
RGPIN-2018-04060 - 财政年份:2021
- 资助金额:
$ 57.35万 - 项目类别:
Discovery Grants Program - Individual
Understanding brain maturation: How spontaneous cortical high frequency oscillations develop and affect executive function during childhood
了解大脑成熟:自发皮质高频振荡如何发展并影响儿童时期的执行功能
- 批准号:
RGPIN-2021-02948 - 财政年份:2021
- 资助金额:
$ 57.35万 - 项目类别:
Discovery Grants Program - Individual
Does menthol affect nicotine's impact on brain reinforcement mechanisms in dependent and nondependent users of electronic nicotine delivery systems?
薄荷醇是否会影响尼古丁对电子尼古丁输送系统的依赖和非依赖用户的大脑强化机制的影响?
- 批准号:
445102 - 财政年份:2021
- 资助金额:
$ 57.35万 - 项目类别:
Operating Grants